Rhenman & Partners Asset Management AB Makes New $1.77 Million Investment in BrightSpring Health Services, Inc. $BTSG

Rhenman & Partners Asset Management AB purchased a new position in BrightSpring Health Services, Inc. (NASDAQ:BTSG) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 60,000 shares of the company’s stock, valued at approximately $1,774,000.

A number of other large investors also recently modified their holdings of the business. EverSource Wealth Advisors LLC bought a new position in BrightSpring Health Services in the 2nd quarter valued at about $43,000. CWM LLC lifted its stake in shares of BrightSpring Health Services by 105.3% in the 3rd quarter. CWM LLC now owns 1,595 shares of the company’s stock worth $47,000 after acquiring an additional 818 shares during the period. Amalgamated Bank lifted its stake in shares of BrightSpring Health Services by 62.7% in the 3rd quarter. Amalgamated Bank now owns 3,041 shares of the company’s stock worth $90,000 after acquiring an additional 1,172 shares during the period. Sandia Investment Management LP bought a new position in shares of BrightSpring Health Services in the second quarter valued at approximately $118,000. Finally, Penserra Capital Management LLC bought a new position in shares of BrightSpring Health Services in the second quarter valued at approximately $139,000.

BrightSpring Health Services Price Performance

BTSG stock opened at $41.49 on Friday. BrightSpring Health Services, Inc. has a one year low of $15.48 and a one year high of $44.87. The firm has a 50-day moving average of $39.50 and a two-hundred day moving average of $33.98. The firm has a market capitalization of $8.03 billion, a PE ratio of 47.15, a P/E/G ratio of 0.55 and a beta of 2.31. The company has a current ratio of 1.57, a quick ratio of 1.12 and a debt-to-equity ratio of 1.32.

BrightSpring Health Services (NASDAQ:BTSG) last released its earnings results on Friday, February 27th. The company reported $0.33 earnings per share for the quarter, missing the consensus estimate of $0.34 by ($0.01). The firm had revenue of $3.55 billion during the quarter, compared to analysts’ expectations of $3.38 billion. BrightSpring Health Services had a return on equity of 12.66% and a net margin of 1.48%.The business’s revenue was up 29.3% on a year-over-year basis. During the same period last year, the business earned $0.11 earnings per share. On average, analysts forecast that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current year.

Insider Buying and Selling at BrightSpring Health Services

In other news, insider Jon B. Rousseau sold 220,000 shares of the firm’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total value of $9,053,000.00. Following the completion of the sale, the insider owned 1,023,880 shares of the company’s stock, valued at $42,132,662. This trade represents a 17.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Lisa A. Nalley sold 30,000 shares of BrightSpring Health Services stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total value of $1,234,500.00. Following the transaction, the insider owned 110,594 shares in the company, valued at $4,550,943.10. This represents a 21.34% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 285,000 shares of company stock valued at $11,727,750 in the last three months. 3.40% of the stock is currently owned by company insiders.

BrightSpring Health Services News Summary

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Zacks added BTSG to its Zacks Rank #1 (Strong Buy) growth list for March 6, highlighting it as a top growth pick. Best Growth Stocks to Buy for March 6th
• Positive Sentiment: Zacks similarly featured BTSG on its March 5 list of best growth / strong-buy stocks, reinforcing buy-side attention across consecutive days. Best Growth Stocks to Buy for March 5th
• Positive Sentiment: Zacks upgraded BTSG from Hold to Strong Buy and published follow-ups pointing to momentum and rising earnings estimate revisions—signals that analysts are lifting near‑term expectations. Zacks.com upgrade
• Positive Sentiment: Zacks published a piece noting surging earnings estimate revisions for BTSG, which is commonly bullish for the stock if revisions translate into higher forward EPS and investor expectations. Surging Earnings Estimates Signal Upside
• Positive Sentiment: Broker commentary (Mizuho) and media noted strong price-appreciation forecasts and heavy trading after the analyst upgrade, which can support further upside if momentum continues. Mizuho Forecasts Strong Price Appreciation Sees Strong Trading Volume After Analyst Upgrade
• Neutral Sentiment: Zacks published comparative coverage showing how BTSG stacks up vs. medical peers this year—useful context but not an immediate catalyst. Peer Performance
• Neutral Sentiment: Reported short-interest figures in the dataset show 0 shares and 0.0 days-to-cover (likely a data artifact). That suggests no clear short-position signal from the reported data and should be treated cautiously.
• Negative Sentiment: Fundamentals remain mixed: the company’s most recent quarterly report showed strong revenue growth but a small EPS miss and the stock trades at a elevated PE, which can make it vulnerable to short-term pullbacks despite positive analyst notes.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. William Blair initiated coverage on BrightSpring Health Services in a report on Monday, December 8th. They set an “outperform” rating on the stock. Wells Fargo & Company boosted their price objective on BrightSpring Health Services from $43.00 to $50.00 and gave the stock an “overweight” rating in a research note on Monday, March 2nd. Mizuho raised their target price on BrightSpring Health Services from $45.00 to $50.00 and gave the company an “outperform” rating in a research note on Tuesday, March 3rd. KeyCorp raised BrightSpring Health Services from a “sector weight” rating to an “overweight” rating and set a $45.00 target price on the stock in a report on Friday, December 12th. Finally, CJS Securities upgraded shares of BrightSpring Health Services to a “strong-buy” rating in a research report on Thursday, December 11th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $44.08.

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.